Study | Diagnosis | n | Dose prescription | Toxicity |
---|---|---|---|---|
Mendez Romero[11] | HCC, Mets | 25 (8, 17) | 10–12.5 Gy × 3 or 5 Gy × 5 (CP B) | 4 RILD ≥ grade 3, one grade 5 (HCC patient with CP B) |
Tse[13] | HCC, IHC | 41 (31, 10) | 4–9 Gy × 6 | 10 (8 HCC, 2 IHC) grade 3 liver enzyme, 3 (2 HCC, 1 IHC) grade 3 hyperbilirubinemia, no grade 4–5 |
Rusthoven[12] | HCC, Mets | 47 (2, 45) | 12–20 Gy × 3 | 1 grade 3 soft-tissue toxicity |
Lee[14] | Mets | 68 | 4.6–10 Gy × 6 | 2 grade 3 liver enzyme changes (d/t DP), but no RILD |
Cardenes[9] | HCC | 17 | 12 Gy × 3 → 16 Gy × 3 (CP A) or 8 Gy × 5 (CP B) | 2 grade 3 liver toxicity in patients with CP B at 42 Gy/3fx |
Son[18] | HCC | 36 | 10–13 Gy × 3 | 12 grade 2 or higher hepatic toxicity, 4 progression of CP |
Present study | HCC | 92 | 10–20 Gy × 3–4 | 11 grade 2, 6 grade 3 or higher RILD |